Novavax, Inc. (NVAX)
NASDAQ: NVAX · IEX Real-Time Price · USD
14.15
+0.08 (0.60%)
Jun 21, 2024, 12:54 PM EDT - Market open

Novavax Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 1994
Net Income
-545.06-657.94-1,743.75-418.26-132.69
Upgrade
Depreciation & Amortization
41.2329.0512.664.895.68
Upgrade
Share-Based Compensation
85.36130.3183.63128.0417.05
Upgrade
Other Operating Activities
-295.4982.651,870242.8-26.65
Upgrade
Operating Cash Flow
-713.97-415.94322.95-42.54-136.62
Upgrade
Capital Expenditures
-58.81-92.99-57.49-54.6216.48
Upgrade
Acquisitions
000-165.520
Upgrade
Change in Investments
00157.64-157.6422.02
Upgrade
Investing Cash Flow
-58.81-92.99100.15-377.7838.49
Upgrade
Share Issuance / Repurchase
360.4248.59589.62881.0198.38
Upgrade
Debt Issued / Paid
-352.3581.66-127.91-96.070
Upgrade
Other Financing Activities
-3.59-5.26-199.82-
Upgrade
Financing Cash Flow
4.47324.99461.71984.7698.38
Upgrade
Exchange Rate Effect
3.274.52-5.292.12-0.03
Upgrade
Net Cash Flow
-765.04-179.41879.52566.560.22
Upgrade
Free Cash Flow
-772.77-508.92265.46-97.16-120.15
Upgrade
Free Cash Flow Margin
-78.56%-25.68%23.16%-20.43%-643.81%
Upgrade
Free Cash Flow Per Share
-7.67-6.513.57-1.69-4.99
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).